Abstract
Parathyroid hormone (PTH) in concert with 1,25-dihydroxyvitamin D regulates the level of calcium and phosphate from skeletal, renal, and intestinal actions. Hyperparathyroidism (HPT) is a common endocrinological disease characterized by an elevated parathyroid hormone (PTH). Hyperparathyroidism can be primary (autonomous hyperfunction of one or more parathyroid glands), secondary (physiological response to hypocalcemia due to an underlying disease), or tertiary (post renal transplantation).
Primary HPT may be minimally symptomatic and coincidentally found. However, the signs and symptoms of hypercalcemia include renal, neurocognitive, musculoskeletal, gastrointestinal, and cardiovascular manifestations. Differential diagnoses that should be considered include vitamin D deficiency, malignancy, familial hypocalciuric hypercalcemia, and lithium or thiazide therapy.
The definitive treatment of primary HPT is parathyroidectomy; however, the clinical and biochemical features may suggest that observation alone is optimal for the patient.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- BMD:
-
Bone mineral density
- CaE:
-
Fractional excretion of calcium
- CaHPO4 :
-
Calcium phosphate
- CaSR:
-
Calcium-sensing receptor
- dRTA:
-
Distal renal tubular acidosis
- FHH:
-
Familial hypocalciuric hypercalcemia
- MEN:
-
Multiple endocrine neoplasia
- PHPT:
-
Primary hyperparathyroidism
- PTA:
-
Proximal renal tubular acidosis
- PTH:
-
Parathyroid hormone
- PTHrP:
-
Parathormone-related peptide
References
Andersson P, Rydberg E, et al. Primary hyperparathyroidism and heart disease–a review. Eur Heart J. 2004;25(20):1776–87.
Bilezikian JP, Brandi ML, et al. Primary hyperparathyroidism: new concepts in clinical, densitometric and biochemical features. J Intern Med. 2005;257(1):6–17.
Bilezikian JP, Khan AA, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocrinol Metab. 2009;94(2):335–9.
Broadus AE, Horst RL, et al. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N Engl J Med. 1980;302(8):421–6.
Christensson T, Hellstrom K, et al. Hypercalcemia and primary hyperparathyroidism. Prevalence in patients receiving thiazides as detected in a health screen. Arch Intern Med. 1977;137(9):1138–42.
Friedman PA, Gesek FA. Calcium transport in renal epithelial cells. Am J Physiol. 1993;264(2 Pt 2):F181–98.
Fuleihan Gel H. Familial benign hypocalciuric hypercalcemia. J Bone Miner Res. 2002;17 Suppl 2:N51–6.
Inzucchi SE. Understanding hypercalcemia. Its metabolic basis, signs, and symptoms. Postgrad Med. 2004;115(4):69–70. 73–6.
Mallette LE, Khouri K, et al. Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab. 1989;68(3):654–60.
Nussbaum SR, Zahradnik RJ, et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem. 1987;33(8):1364–7.
Pfister MF, Lederer E, et al. Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters. J Biol Chem. 1997;272(32):20125–30.
Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab. 1996;81(6):2036–40.
Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005;352(4):373–9.
Talmage RV, Elliott JR. Removal of calcium from bone as influenced by the parathyroids. Endocrinology. 1958;62(6):717–22.
Tordjman KM, Greenman Y, et al. Characterization of normocalcemic primary hyperparathyroidism. Am J Med. 2004;117(11):861–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Konya, J., Aye, M., England, R.J., Atkin, S.L. (2014). Assessment of Hyperparathyroidism. In: Watkinson, J., Scott-Coombes, D. (eds) Tips and Tricks in Endocrine Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-2146-6_31
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2146-6_31
Published:
Publisher Name: Springer, London
Print ISBN: 978-0-85729-982-6
Online ISBN: 978-1-4471-2146-6
eBook Packages: MedicineMedicine (R0)